A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
NCT03070301
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
LEE011
DRUG:
everolimus
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
[object Object]
[object Object]
[object Object]